No abstract available
MeSH terms
-
Amyloid / blood
-
Amyloidosis / blood
-
Amyloidosis / diagnosis*
-
Amyloidosis / drug therapy
-
Amyloidosis / pathology
-
Antifibrinolytic Agents / administration & dosage
-
Antineoplastic Agents, Alkylating / administration & dosage
-
Antineoplastic Agents, Hormonal / administration & dosage
-
Blood Coagulation / drug effects
-
Blood Coagulation Factors / metabolism
-
Dexamethasone / administration & dosage
-
Disseminated Intravascular Coagulation / blood
-
Disseminated Intravascular Coagulation / diagnosis*
-
Disseminated Intravascular Coagulation / drug therapy
-
Disseminated Intravascular Coagulation / pathology
-
Female
-
Humans
-
Immunoglobulin kappa-Chains / blood
-
International Normalized Ratio
-
Melphalan / administration & dosage
-
Middle Aged
-
Nephrotic Syndrome / blood
-
Nephrotic Syndrome / diagnosis*
-
Nephrotic Syndrome / drug therapy
-
Nephrotic Syndrome / pathology
-
Partial Thromboplastin Time
-
Vitamin K / administration & dosage
Substances
-
Amyloid
-
Antifibrinolytic Agents
-
Antineoplastic Agents, Alkylating
-
Antineoplastic Agents, Hormonal
-
Blood Coagulation Factors
-
Immunoglobulin kappa-Chains
-
Vitamin K
-
Dexamethasone
-
Melphalan